CollPlant Biotechnologies
CLGN
19 hedge funds and large institutions have $4.08M invested in CollPlant Biotechnologies in 2025 Q3 according to their latest regulatory filings, with 4 funds opening new positions, 3 increasing their positions, 4 reducing their positions, and 2 closing their positions.
100% more first-time investments, than exits
New positions opened: 4 | Existing positions closed: 2
61% more capital invested
Capital invested by funds: $2.53M → $4.08M (+$1.54M)
12% more funds holding
Funds holding: 17 → 19 (+2)
2.86% less ownership
Funds ownership: 14.78% → 11.92% (-2.9%)
25% less repeat investments, than reductions
Existing positions increased: 3 | Existing positions reduced: 4
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
SDJVC
St. Denis J. Villere & Co
New Orleans,
Louisiana
|
+$99.8K |
| 2 |
AE
AMH Equity
Great Neck,
New York
|
+$93.3K |
| 3 |
Brown Advisory
Baltimore,
Maryland
|
+$18K |
| 4 |
FIA
FNY Investment Advisers
New York
|
+$12.5K |
| 5 |
Group One Trading
Chicago,
Illinois
|
+$11.9K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
HCM
Heights Capital Management
San Francisco,
California
|
-$610K |
| 2 |
AFM
Anson Funds Management
Dallas,
Texas
|
-$217K |
| 3 |
Renaissance Technologies
New York
|
-$47K |
| 4 |
Pathstone Holdings
Englewood,
New Jersey
|
-$40.5K |
| 5 |
TSS
Two Sigma Securities
New York
|
-$14.1K |
CLGN Hedge Fund Activity: Q3 2025 in Review
19 of the 7,646 institutional investors tracked by Wall St. Rank reported a position in CollPlant Biotechnologies (CLGN) for Q3 2025, worth a combined $4.08M — up 61% from $2.53M a quarter earlier.
Buyers outnumbered sellers: 4 funds opened new CLGN positions and 2 closed out — a net gain of 2 holders — while 3 added to existing stakes and 4 trimmed.
The largest buyer was St. Denis J. Villere & Co, adding an estimated $99.8K. The largest seller was Heights Capital Management, cutting an estimated $610K.
- 19 institutional investors held CollPlant Biotechnologies (CLGN) as of Q3 2025, up from 17 in Q2 2025.
- Funds reported $4.08M of CollPlant Biotechnologies stock for Q3 2025, up 61% quarter-over-quarter.
- 4 funds opened new CollPlant Biotechnologies positions in Q3 2025 and 2 closed out, a net change of +2 holders.
- The largest CollPlant Biotechnologies buyer in Q3 2025 was St. Denis J. Villere & Co, an estimated $99.8K added.
- The largest CollPlant Biotechnologies seller in Q3 2025 was Heights Capital Management, an estimated $610K sold.
Based on aggregated 13F filings for Q3 2025.